Medical Device Roundtable Discussion, March 2014
The economic downturn has caused medical device venture capital financing to change. Major shifts are being seen when identifying the stage at which companies exit and modifications are being absorbed into the regulatory approvals, which are now more difficult to obtain than they were in the past.
At the March 2014 Medical Device Roundtable session, Revital Hirsch of SCP Vitalife discussed key milestones in the lifecycle of a medical device company from inception to exit and stages in between.
To access key points from the Roundtable, please click here.